ScholarIQanswers from OpenAlex & ORCID
Merit Cudkowicz
ResearcherPublications, citations & collaboration network
Merit Cudkowicz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Merit Cudkowicz have?
ScholarIQindexed works
Merit Cudkowicz has 428 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Merit Cudkowicz have?
ScholarIQcitation count
Merit Cudkowicz has 29,278 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Merit Cudkowicz?
ScholarIQh-index
Merit Cudkowicz has an h-index of 93 in OpenAlex.
What is the i10-index of Merit Cudkowicz?
ScholarIQi10-index
Merit Cudkowicz has an i10-index of 257 in OpenAlex.
What is the ORCID of Merit Cudkowicz?
ScholarIQorcid
The ORCID for Merit Cudkowicz is on the source record.
What is the OpenAlex record for Merit Cudkowicz?
ScholarIQopenalex
The OpenAlex for Merit Cudkowicz is on the source record.
What are the most-cited papers on Merit Cudkowicz?
ScholarIQmost cited works
Gait variability and basal ganglia disorders: Stride‐to‐stride variations of gait cycle timing in parkinson's disease and Huntington's disease
Jeffrey M. Hausdorff, Merit Cudkowicz, Renée Firtion, Jeanne Y. Wei, Ary L. Goldberger
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Jonathan Mill, Merit Cudkowicz, Angela Genge, Pamela J. Shaw, Gen Sobue, Robert C. Bucelli, Adriano Chiò, Philip Van Damme, Albert C. Ludolph, Jonathan D. Glass, Jinsy Andrews, Suma Babu, Michael Benatar, Christopher McDermott, Thos Cochrane, Sowmya Chary, Sheena Chew, Han Zhu, Fan Wu, Ivan Nestorov, Danielle Graham, Peng Sun, Manjit McNeill, Laura Fanning, Toby A. Ferguson, Stephanie Fradette
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS
Jonathan Mill, Merit Cudkowicz, Pamela J. Shaw, Peter M. Andersen, Nazem Atassi, Robert C. Bucelli, Angela Genge, Jonathan D. Glass, Shafeeq Ladha, Albert Ludolph, Nicholas J. Maragakis, Christopher McDermott, Alan Pestronk, John Ravits, François Salachas, Randall Trudell, Philip Van Damme, Lorne Zinman, C. Frank Bennett, Roger Lane, Alfred Sandrock, Heiko Runz, Danielle Graham, Hani Houshyar, Alexander McCampbell, Ivan Nestorov, Ih Chang, Manjit McNeill, Laura Fanning, Stephanie Fradette, Toby A. Ferguson
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry Heiman‐Patterson, Carlayne E. Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq Ladha, Jonathan Mill, Stephen N. Scelsa, Tuan Vu, Christina Fournier, Jonathan D. Glass, Kristin Johnson, Andrea Swenson, Namita Goyal, Gary L. Pattee, Patricia L. Andres, Suma Babu, Marianne Chase, Derek D’Agostino, Samuel P. Dickson, Noel Ellison, Meghan Hall, Kent Hendrix, Gale Kittle, Michelle McGovern, Joseph Ostrow, Lindsay Pothier, Rebecca Randall, Jeremy M. Shefner, Alexander Sherman, Eric Tustison, Prasha Vigneswaran, Jason Walker, Hong Yu, James Chan, Janet Wittes, Joshua Cohen, Justin Klee, Kent Leslie, Rudolph E. Tanzi, Walter Gilbert, Patrick Yeramian, David Schoenfeld, Merit Cudkowicz
A clinical trial of creatine in ALS
Jeremy M. Shefner, Merit Cudkowicz, David Schoenfeld, Thomas Conrad, J Taft, Mark Chilton, Leo Urbinelli, Muddasir Qureshi, Haohan Zhang, Alan Pestronk, James B. Caress, P. D. Donofrio, Eric J. Sorenson, Walter G. Bradley, Catherine Lomen‐Hoerth, Erik P. Pioro, Kourosh Rezania, Matthew O. Ross, Robert M. Pascuzzi, Terry Heiman‐Patterson, Rup Tandan, Hiroshi Mitsumoto, J. D. Rothstein, Truis Smith‐Palmer, Daniel J. MacDonald, Darren Burke